Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference53 articles.
1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015;Ostrom;Neuro-Oncology,2018
2. Novel Treatment Strategies for Glioblastoma-A Summary;Stylli;Cancers (Basel),2021
3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005
4. Temozolomide resistance in glioblastoma multiforme;Lee;Genes Dis.,2016
5. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy;Biomaterials;2024-12
2. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12
3. Revisiting the potential of regulated cell death in glioma treatment: a focus on autophagy-dependent cell death, anoikis, ferroptosis, cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk between them;Frontiers in Oncology;2024-08-09
4. Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment;Biomedicine & Pharmacotherapy;2024-08
5. Sonodynamic therapy for adult-type diffuse gliomas: past, present, and future;Journal of Neuro-Oncology;2024-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3